Peak Financial Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-24,675
Closed -$1.55M 80
2026
Q1
$1.55M Buy
24,675
+5,205
+27% +$416K 0.69% 38
2025
Q4
$1.86M Buy
19,470
+12,788
+191% +$1.25M 0.83% 37
2025
Q3
$652K Buy
6,682
+2,131
+47% +$221K 0.31% 57
2025
Q2
$489K Buy
+4,551
New +$460K 0.25% 63

Other funds holding BSX

Peak Financial Advisors's BSX Position: Q2 2026 in Review

Peak Financial Advisors sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 24,675 shares — an estimated $1.55M sold.

Peak Financial Advisors first reported a position in BSX in Q2 2025 and held it in 4 quarters. The position peaked at $1.86M in Q4 2025. 241 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Peak Financial Advisors reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Peak Financial Advisors sold 24,675 Boston Scientific shares in Q2 2026, an estimated $1.55M.
  • Peak Financial Advisors first reported a position in Boston Scientific in Q2 2025 and held it in 4 quarters.
  • Peak Financial Advisors's Boston Scientific position peaked at $1.86M in Q4 2025.
  • 241 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Peak Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.